je.st
news
Tag: amag
OnSSI's Ocularis 5 is Now Certified with AMAG Technology's Symmetry Access Control System
2016-02-24 11:31:09| Industrial Newsroom - All News for Today
Pearl River, NY OnSSI announces that it is now a certified member of AMAG Technologys Symmetry Preferred Partner Program and its Ocularis 5.1 Video Management Software is now certified with AMAGs Symmetry Access Control v8.0.2 and future Symmetry v8 versions. With testing and certification having been completed...
Tags: system
control
access
certified
AMAG Pharmaceuticals: Strong Growth Biotech At An Undervalued Price
2015-09-09 15:11:37| Biotech - Topix.net
Build a market-beating portfolio of high-quality, reasonably-priced momentum stocks by following a top stock-picker Learn moreA AMAG Pharmaceuticals initially increased 245% from the time my last article on the company was written back in May 2014 to when the stock peaked in July 2015. After the recent sell-off, the stock is still up 173%.
Tags: price
strong
growth
biotech
AMAG Technology Unveils Complete Suite of Video Solutions
2015-04-09 12:31:14| Industrial Newsroom - All News for Today
TORRANCE, Calif. - AMAG Technology has entered into a technology partnership with Salient Systems, Inc. and will offer Salient's CompleteView Video Management System, PowerProtect NVR Server Platforms and TouchView Mobile Video Apps under the Symmetry brand. The Symmetry Security Management platform brings...
Tags: video
complete
technology
solutions
Triferic: The Kill Shot For AMAG Pharmaceuticals' Feraheme
2015-01-28 14:36:45| Biotech - Topix.net
Cruise-1/-2 Phase III trials met all primary and secondary endpoints with safety equivalent to placebo resulting in a highly differentiated and disruptive new entry into CKD market. AMAG Pharmaceuticals has issued puzzling guidance for Feraheme in 2015: Sales are projected to grow from ~$86 Million in 2014 to a range of approximately $86-102 MM in 2015 .
Tags: shot
kill
pharmaceuticals
amag
Short AMAG Pharmaceuticals After Poor Acquisition
2015-01-10 18:21:57| Biotech - Topix.net
AMAG Pharmaceuticals , formerly known as Advanced Magnetics, was a high-flying biotech stock in the mid-2000s, with a peak share price of $71.45 in late 2006. The company had elicited widespread investor interest in its novel IV iron product , with the strategy of achieving a very broad-label indication for iron-deficient anemia by running a very comprehensive series of clinical trials involving nearly 2,000 patients.
Tags: short
poor
acquisition
pharmaceuticals